These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 31033729)

  • 1. Systems serology for decoding infection and vaccine-induced antibody responses to HIV-1.
    Pittala S; Morrison KS; Ackerman ME
    Curr Opin HIV AIDS; 2019 Jul; 14(4):253-264. PubMed ID: 31033729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems serology for evaluation of HIV vaccine trials.
    Ackerman ME; Barouch DH; Alter G
    Immunol Rev; 2017 Jan; 275(1):262-270. PubMed ID: 28133810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contrasting Adult and Infant Immune Responses to HIV Infection and Vaccination.
    Martinez DR; Permar SR; Fouda GG
    Clin Vaccine Immunol; 2016 Feb; 23(2):84-94. PubMed ID: 26656117
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antibody response in HIV-1-infected donors.
    Richardson SI; Moore PL
    Curr Opin HIV AIDS; 2019 Jul; 14(4):233-239. PubMed ID: 31033730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of Vaccine-Induced CD4 T Cell Functional Profiles by Changes in Components of HIV Vaccine Regimens in Humans.
    Pissani F; Schulte B; Eller MA; Schultz BT; Ratto-Kim S; Marovich M; Thongcharoen P; Sriplienchan S; Rerks-Ngarm S; Pitisuttithum P; Esser S; Alter G; Robb ML; Kim JH; Michael NL; Streeck H
    J Virol; 2018 Dec; 92(23):. PubMed ID: 30209165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy?
    Subbaraman H; Schanz M; Trkola A
    Retrovirology; 2018 Jul; 15(1):52. PubMed ID: 30055627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Broadly Neutralizing Antibodies Against HIV: New Insights to Inform Vaccine Design.
    Sadanand S; Suscovich TJ; Alter G
    Annu Rev Med; 2016; 67():185-200. PubMed ID: 26565674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HIV Vaccines: One Step Closer.
    Low MSY; Tarlinton D
    Trends Mol Med; 2017 Jan; 23(1):1-3. PubMed ID: 27889424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systems serology: profiling vaccine induced humoral immunity against HIV.
    Chung AW; Alter G
    Retrovirology; 2017 Dec; 14(1):57. PubMed ID: 29268769
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HIV-1 phylogenetics and vaccines.
    Rolland M
    Curr Opin HIV AIDS; 2019 May; 14(3):227-232. PubMed ID: 30925535
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvants: tailoring humoral immune responses.
    McElrath MJ
    Curr Opin HIV AIDS; 2017 May; 12(3):278-284. PubMed ID: 28257301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Antibodiome-Mapping the Humoral Immune Response to HIV.
    Butler AL; Fischinger S; Alter G
    Curr HIV/AIDS Rep; 2019 Apr; 16(2):169-179. PubMed ID: 30903381
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospects for a globally effective HIV-1 vaccine.
    Excler JL; Robb ML; Kim JH
    Vaccine; 2015 Nov; 33 Suppl 4():D4-12. PubMed ID: 26100921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting broadly neutralizing antibody precursors: a naïve approach to vaccine design.
    McGuire AT
    Curr Opin HIV AIDS; 2019 Jul; 14(4):294-301. PubMed ID: 30946041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers.
    Landais E; Moore PL
    Retrovirology; 2018 Sep; 15(1):61. PubMed ID: 30185183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Broadly neutralizing antibodies against HIV-1: templates for a vaccine.
    van Gils MJ; Sanders RW
    Virology; 2013 Jan; 435(1):46-56. PubMed ID: 23217615
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlates of broadly neutralizing antibody development.
    Abela IA; Kadelka C; Trkola A
    Curr Opin HIV AIDS; 2019 Jul; 14(4):279-285. PubMed ID: 31107283
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of humoral immunity in host defense against HIV.
    Baum LL
    Curr HIV/AIDS Rep; 2010 Feb; 7(1):11-8. PubMed ID: 20425053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current views on the potential for development of a HIV vaccine.
    Cohen KW; Frahm N
    Expert Opin Biol Ther; 2017 Mar; 17(3):295-303. PubMed ID: 28095712
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between HIV-1 clades and HIV-1 antibody neutralization sensitivity: significant for vaccine development?
    van Gils MJ; Schuitemaker H
    Curr HIV Res; 2010 Dec; 8(8):579-86. PubMed ID: 21054254
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.